For: | Lam T, Burns K, Dennis M, Cheung NW, Gunton JE. Assessment of cardiovascular risk in diabetes: Risk scores and provocative testing. World J Diabetes 2015; 6(4): 634-641 [PMID: 25987961 DOI: 10.4239/wjd.v6.i4.634] |
---|---|
URL: | https://www.wjgnet.com/1948-9358/full/v6/i4/634.htm |
Number | Citing Articles |
1 |
S. Kou, J.Y. Cao, S. Yeo, D.J. Holmes-Walker, S.L. Lau, J.E. Gunton. Ethnicity influences cardiovascular outcomes and complications in patients with type 2 diabetes. Journal of Diabetes and its Complications 2018; 32(2): 144 doi: 10.1016/j.jdiacomp.2017.10.016
|
2 |
Chanchal Chandramouli, Melissa E. Reichelt, Claire L. Curl, Upasna Varma, Laura A. Bienvenu, Parisa Koutsifeli, Antonia J. A. Raaijmakers, Miles J. De Blasio, Cheng Xue Qin, Alicia J. Jenkins, Rebecca H. Ritchie, Kimberley M. Mellor, Lea M. D. Delbridge. Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20703-8
|
3 |
Marco Herbsleb, Andy Schumann, Berend Malchow, Christian Puta, P. Christian Schulze, Holger W. Gabriel, Karl-Jürgen Bär. Chronotropic incompetence of the heart is associated with exercise intolerance in patients with schizophrenia. Schizophrenia Research 2018; 197: 162 doi: 10.1016/j.schres.2018.02.020
|
4 |
Marie-Claire Fava, Sascha Reiff, Joseph Azzopardi, Stephen Fava. Time trajectories of key cardiometabolic parameters and of cardiovascular risk in subjects with diabetes in a real world setting. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2023; 17(6): 102777 doi: 10.1016/j.dsx.2023.102777
|
5 |
Karolina Tchórzewska, Jakub Tchórzewski, Adam Rzeźnicki, Dominika Cichońska-Rzeźnicka, Andrzej Szpak, Jan Krakowiak. Dissemination of Selected Risk Factors for Cardiovascular Diseases Among Patients Using Primary Health Care in the Lodz Voivodeship. Journal of Health Study and Medicine 2023; 2023(1): 21 doi: 10.2478/jhsm-2023-0002
|
6 |
Hana Kahleova, Terezie Pelikanova. Vegetarian and Plant-Based Diets in Health and Disease Prevention. 2017; : 369 doi: 10.1016/B978-0-12-803968-7.00021-6
|
7 |
Nebojsa Kavaric, Aleksandra Klisic, Ana Ninic. Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetes. Open Medicine 2018; 13(1): 610 doi: 10.1515/med-2018-0086
|
8 |
Ehimen Phyllis Odum, Ekenechukwu Esther Young. Elevated cardiac troponin I, creatine kinase and myoglobin and their relationship with cardiovascular risk factors in patients with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018; 12(2): 141 doi: 10.1016/j.dsx.2017.12.001
|
9 |
James J. Chamberlain, Eric L. Johnson, Sandra Leal, Andrew S. Rhinehart, Jay H. Shubrook, Lacie Peterson. Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018. Annals of Internal Medicine 2018; 168(9): 640 doi: 10.7326/M18-0222
|
10 |
Christos Damaskos, Nikolaos Garmpis, Paraskevi Kollia, Georgios Mitsiopoulos, Danai Barlampa, Athanasios Drosos, Alexandros Patsouras, Nikolaos Gravvanis, Vasileios Antoniou, Alexandros Litos, Evangelos Diamantis. Assessing Cardiovascular Risk in Patients with Diabetes: An Update. Current Cardiology Reviews 2021; 16(4): 266 doi: 10.2174/1573403X15666191111123622
|
11 |
Yazid N. Al Hamarneh, Brenda R. Hemmelgarn, Imran Hassan, Charlotte A. Jones, Ross T. Tsuyuki. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled R x EACH Trial. Canadian Journal of Diabetes 2017; 41(6): 580 doi: 10.1016/j.jcjd.2017.08.244
|
12 |
Meghan A Jardine, Hana Kahleova, Susan M Levin, Zeeshan Ali, Caroline B Trapp, Neal D Barnard. Perspective: Plant-Based Eating Pattern for Type 2 Diabetes Prevention and Treatment: Efficacy, Mechanisms, and Practical Considerations. Advances in Nutrition 2021; 12(6): 2045 doi: 10.1093/advances/nmab063
|
13 |
Amel Fayed, Rasmieh Alzeidan, Roaa Elkouny, Marwa Tawfik, Rania Naguib. Cardiovascular Risk Among Patients with Controlled and Uncontrolled Type 2 Diabetes: A Sub-Cohort Analysis from the Heart Health Promotion (HHP) Study. International Journal of General Medicine 2023; : 1171 doi: 10.2147/IJGM.S404054
|
14 |
Atsuko Yokota, Shuji Gamoh, Naoko Tanaka-Totoribe, Tatsuo Shiba, Masachika Kuwabara, Eisaku Nakamura, Takahiro Hayase, Hiroaki Hisa, Kunihide Nakamura, Ryuichi Yamamoto. Angiotensin II, as well as 5-hydroxytriptamine, is a potent vasospasm inducer of saphenous vein graft for coronary artery bypass grafting in patients with diabetes mellitus. Biochemistry and Biophysics Reports 2016; 6: 82 doi: 10.1016/j.bbrep.2016.03.008
|